Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 197

Similar articles for PubMed (Select 19179893)

1.

Patterns of cardiac perfusion abnormalities after chemoradiotherapy in patients with lung cancer.

Gayed IW, Liu HH, Wei X, Liao Z, Yusuf SW, Chang JY, Bassett R, Komaki R.

J Thorac Oncol. 2009 Feb;4(2):179-84. doi: 10.1097/JTO.0b013e3181990c46.

PMID:
19179893
2.

The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung cancer after chemoradiation therapy.

Gayed I, Gohar S, Liao Z, McAleer M, Bassett R, Yusuf SW.

Int J Cardiovasc Imaging. 2009 Jun;25(5):487-95. doi: 10.1007/s10554-009-9440-7. Epub 2009 Feb 22.

PMID:
19234869
3.

The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer.

Gayed IW, Liu HH, Yusuf SW, Komaki R, Wei X, Wang X, Chang JY, Swafford J, Broemeling L, Liao Z.

J Nucl Med. 2006 Nov;47(11):1756-62.

4.

High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL.

Pijls-Johannesma M, Houben R, Boersma L, Grutters J, Seghers K, Lambin P, Wanders R, De Ruysscher D.

Radiother Oncol. 2009 Jun;91(3):443-8. doi: 10.1016/j.radonc.2009.02.010. Epub 2009 Mar 16.

PMID:
19297049
5.

Computed tomography assessment of lung density in patients with lung cancer treated with accelerated hypofractionated radio-chemotherapy supported with amifostine.

Koukourakis MI, Tsoutsou PG, Abatzoglou I.

Am J Clin Oncol. 2009 Jun;32(3):258-61. doi: 10.1097/COC.0b013e3181845557.

PMID:
19349852
6.

Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.

Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM.

Cancer. 2009 Sep 15;115(18):4156-66. doi: 10.1002/cncr.24492.

7.

[Treatment outcome of locally advanced stage IIIA/B lung cancer].

Cicenas S, Zaliene A, Atkocius V.

Medicina (Kaunas). 2009;45(6):452-9. Lithuanian.

8.

Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution.

Lind PA, Pagnanelli R, Marks LB, Borges-Neto S, Hu C, Zhou SM, Light K, Hardenbergh PH.

Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):914-20.

PMID:
12605969
9.

[Utility of SPECT lung perfusion scans in assessing early changes in pulmonary function of patients with lung cancer after radiotherapy].

Zhang WJ, Zheng R, Zhao LJ, Wang LH, Chen SZ.

Ai Zheng. 2004 Oct;23(10):1180-4. Chinese.

PMID:
15473931
10.

Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results.

Hardenbergh PH, Munley MT, Bentel GC, Kedem R, Borges-Neto S, Hollis D, Prosnitz LR, Marks LB.

Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):1023-8.

PMID:
11240243
11.

Symptomatic cardiac events following radiation therapy for left-sided breast cancer: possible association with radiation therapy-induced changes in regional perfusion.

Yu X, Prosnitz RR, Zhou S, Hardenberg PH, Tisch A, Blazing MA, Borges-Neto S, Hollis D, Wong T, Marks LB.

Clin Breast Cancer. 2003 Aug;4(3):193-7.

PMID:
14499012
13.

Lung perfusion imaging can risk stratify lung cancer patients for the development of pulmonary complications after chemoradiation.

Gayed IW, Chang J, Kim EE, Nuñez R, Chasen B, Liu HH, Kobayashi K, Zhang Y, Liao Z, Gohar S, Jeter M, Henderson L, Erwin W, Komaki R.

J Thorac Oncol. 2008 Aug;3(8):858-64. doi: 10.1097/JTO.0b013e31818020d5.

14.

Preoperative risk stratification using gated myocardial perfusion studies in patients with cancer.

Chang K, Sarkiss M, Won KS, Swafford J, Broemeling L, Gayed I.

J Nucl Med. 2007 Mar;48(3):344-8.

15.

Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer.

Shioyama Y, Jang SY, Liu HH, Guerrero T, Wang X, Gayed IW, Erwin WD, Liao Z, Chang JY, Jeter M, Yaremko BP, Borghero YO, Cox JD, Komaki R, Mohan R.

Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1349-58. Epub 2007 Apr 18.

PMID:
17446001
16.

Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.

Rodríguez N, Algara M, Foro P, Lacruz M, Reig A, Membrive I, Lozano J, López JL, Quera J, Fernández-Velilla E, Sanz X.

Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):810-7. doi: 10.1016/j.ijrobp.2008.04.064. Epub 2008 Aug 26.

PMID:
18755556
17.

The incidence and functional consequences of RT-associated cardiac perfusion defects.

Marks LB, Yu X, Prosnitz RG, Zhou SM, Hardenbergh PH, Blazing M, Hollis D, Lind P, Tisch A, Wong TZ, Borges-Neto S.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):214-23.

PMID:
16111592
18.

Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer.

Watkins JM, Wahlquist AE, Shirai K, Garrett-Mayer E, Aguero EG, Fortney JA, Sherman CA, Sharma AK.

Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1108-13. doi: 10.1016/j.ijrobp.2008.09.013. Epub 2008 Dec 10.

PMID:
19084345
19.

Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.

Bellière A, Girard N, Chapet O, Khodri M, Kubas A, Souquet PJ, Mornex F.

Cancer Radiother. 2009 Jul;13(4):298-304. doi: 10.1016/j.canrad.2009.04.004. Epub 2009 Jun 13.

PMID:
19525134
20.

Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer.

Fox J, Ford E, Redmond K, Zhou J, Wong J, Song DY.

Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):341-8. doi: 10.1016/j.ijrobp.2008.07.063. Epub 2008 Nov 27.

PMID:
19038504
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk